Jeff E. Knight - Net Worth and Insider Trading

Jeff E. Knight Net Worth

The estimated net worth of Jeff E. Knight is at least $3 Million dollars as of 2025-05-03. Jeff E. Knight is the COO of Crinetics Pharmaceuticals Inc and owns about 87,491 shares of Crinetics Pharmaceuticals Inc (CRNX) stock worth over $3 Million. Details can be seen in Jeff E. Knight's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeff E. Knight has not made any transactions after 2025-03-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Jeff E. Knight

To

Jeff E. Knight Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeff E. Knight owns 1 companies in total, including Crinetics Pharmaceuticals Inc (CRNX) .

Click here to see the complete history of Jeff E. Knight’s form 4 insider trades.

Insider Ownership Summary of Jeff E. Knight

Ticker Company Transaction Date Type of Owner
CRNX Crinetics Pharmaceuticals Inc 2025-03-19 Chief Operating Officer

Jeff E. Knight Latest Holdings Summary

Jeff E. Knight currently owns a total of 1 stock. Jeff E. Knight owns 87,491 shares of Crinetics Pharmaceuticals Inc (CRNX) as of March 19, 2025, with a value of $3 Million.

Latest Holdings of Jeff E. Knight

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRNX Crinetics Pharmaceuticals Inc 2025-03-19 87,491 33.76 2,953,696

Holding Weightings of Jeff E. Knight


Jeff E. Knight Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeff E. Knight has made a total of 6 transactions in Crinetics Pharmaceuticals Inc (CRNX) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Crinetics Pharmaceuticals Inc is the sale of 7,162 shares on March 19, 2025, which brought Jeff E. Knight around $244,940.

Insider Trading History of Jeff E. Knight

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeff E. Knight Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jeff E. Knight Ownership Network

Ownership Network List of Jeff E. Knight

No Data

Ownership Network Relation of Jeff E. Knight

Insider Network Chart

Jeff E. Knight's Executive Compensation Overview

Company Year Salary($) Bonus($) Stock Awards($) Option Awards($) Equity Awards($) Non-Equity Incentive Plan($) All Other Compensation($) Change in Pension and Deferred Comp($) Total($)
Crinetics Pharmaceuticals Inc 2023 459,167 N/A 579,380 1,125,670 N/A 195,145 3,000 N/A 2,362,362
LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT
LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT LIMIT

Jeff E. Knight Owned Company Details

What does Crinetics Pharmaceuticals Inc do?

Who are the key executives at Crinetics Pharmaceuticals Inc?

Jeff E. Knight is the Chief Operating Officer of Crinetics Pharmaceuticals Inc. Other key executives at Crinetics Pharmaceuticals Inc include Chief Development Officer Dana Pizzuti , director & See Remarks Richard Scott Struthers , and Chief Scientific Officer Stephen F. Betz .

Crinetics Pharmaceuticals Inc (CRNX) Insider Trades Summary

Over the past 18 months, Jeff E. Knight made 5 insider transaction in Crinetics Pharmaceuticals Inc (CRNX) with a net sale of 67,978. Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 45,805 shares made by Stephen F. Betz , a net sale of 114,187 shares made by Dana Pizzuti , and a net sale of 118,127 shares made by Marc Wilson .

In summary, during the past 3 months, insiders sold 32,785 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 32,785 shares. During the past 18 months, 629,334 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 629,334 shares.

Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Crinetics Pharmaceuticals Inc Insider Transactions

No Available Data

Jeff E. Knight Mailing Address

Above is the net worth, insider trading, and ownership report for Jeff E. Knight. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Jeff E. Knight's mailing address is: San Diego Ca 92121.